The technology relates to systems and methods for providing medicine recommendations using a population model generated from aggregate patient information. The systems and methods include a feedback system whereby the efficacy and side effects experienced by patients can be linked to their genetic information to enhance the accuracy of the population model.
G16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 70/40 - ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
2.
APPARATUS, SYSTEM AND METHODS FOR PROCESSING OF HARVESTED CANNABIS PLANT MATERIAL
The present technology is directed towards providing an apparatus, system and method for the cost-effective extraction of compounds of interest, such as CBD and THC, from freshly harvested cannabis plant material. The system includes a processing module with a tank that has a flow path to a separator. The tanks are filled with a cooling agent and cannabis plant material which is immersed and agitated to break up the plant material. The filtered outflow from the tank is a filtrate of a mixture of cooling agent and broken up plant material that is transferred to the separator to separate out at least some trichomes containing the compounds of interest.
B01D 29/23 - Supported filter elements arranged for outward flow filtration
B01D 33/06 - Filters with filtering elements which move during the filtering operation with rotary cylindrical filtering surfaces, e.g. hollow drums
B01D 33/15 - Filters with filtering elements which move during the filtering operation with rotary plane filtering surfaces
B01D 33/48 - Regenerating the filter material in the filter by flushing, e.g. counter-current air-bumps
B01D 36/02 - Combinations of filters of different kinds
B02C 23/36 - Adding fluid, other than for crushing or disintegrating by fluid energy the crushing or disintegrating zone being submerged in liquid
B02C 23/40 - Adding fluid, other than for crushing or disintegrating by fluid energy with more than one means for adding fluid to the material being crushed or disintegrated
3.
APPARATUS, SYSTEM AND METHODS FOR PROCESSING OF HARVESTED CANNABIS PLANT MATERIAL
The present technology is directed towards providing an apparatus, system and method for the cost-effective extraction of compounds of interest, such as CBD and THC, from freshly harvested cannabis plant material. The system includes multiple processing modules, each having an agitator, tank and filter basket and is communicative with a separator. The tanks are filled with a cooling agent and the filter baskets provided with cannabis plant material which is immersed and agitated in each tank. The filtered outflow from each tank is a mixture of cooling agent and cannabis plant material that is transferred to a separator to extract the compounds of interest. The filtered outflow from each processing mod-ule is timed to provide a continuous flow rate to the separator.
The present technology is directed towards providing an apparatus, system and method for the cost-effective extraction of compounds of interest, such as CBD and THC, from freshly harvested cannabis plant material. The system includes multiple processing modules, each having an agitator, tank and filter basket and is communicative with a separator. The tanks are filled with a cooling agent and the filter baskets provided with cannabis plant material which is immersed and agitated in each tank. The filtered outflow from each tank is a mixture of cooling agent and cannabis plant material that is transferred to a separator to extract the compounds of interest. The filtered outflow from each processing module is timed to provide a continuous flow rate to the separator.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
The present technology is directed towards providing an apparatus, system and method for the cost-effective extraction of compounds of interest, such as CBD and THC, from freshly harvested cannabis plant material. The system includes multiple processing modules, each having an agitator, tank and filter basket and is communicative with a separator. The tanks are filled with a cooling agent and the filter baskets provided with cannabis plant material which is immersed and agitated in each tank. The filtered outflow from each tank is a mixture of cooling agent and cannabis plant material that is transferred to a separator to extract the compounds of interest. The filtered outflow from each processing module is timed to provide a continuous flow rate to the separator.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
The present technology is directed towards providing an apparatus, system and method for the cost-effective extraction of compounds of interest, such as CBD and THC, from freshly harvested cannabis plant material. The system includes a processing module with a tank that has a flow path to a separator. The tanks are filled with a cooling agent and cannabis plant material which is immersed and agitated to break up the plant material. The filtered outflow from the tank is a filtrate of a mixture of cooling agent and broken up plant material that is transferred to a separator to extract trichomes containing the compounds of interest. The flow path includes recirculation loops that returns at least some of the filtrate back to the tank for further processing.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
The present technology is directed towards providing an apparatus, system and method for the cost-effective extraction of compounds of interest, such as CBD and THC, from freshly harvested cannabis plant material. The system includes a processing module with a tank that has a flow path to a separator. The tanks are filled with a cooling agent and cannabis plant material which is immersed and agitated to break up the plant material. The filtered outflow from the tank is a filtrate of a mixture of cooling agent and broken up plant material that is transferred to the separator to separate out at least some trichomes containing the compounds of interest.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
The present technology is directed towards providing an apparatus, system and method for the cost-effective extraction of compounds of interest, such as CBD and THC, from freshly harvested cannabis plant material. The system includes a processing module with a tank that has a flow path to a separator. The tanks are filled with a cooling agent and cannabis plant material which is immersed and agitated to break up the plant material. The filtered outflow from the tank is a filtrate of a mixture of cooling agent and broken up plant material that is transferred to the separator to separate out at least some trichomes containing the compounds of interest.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
The present technology is directed towards providing an apparatus, system and method for the cost-effective extraction of compounds of interest, such as CBD and THC, from freshly harvested cannabis plant material. Once a tank has been filled with a cooling agent, a first filter basket containing the cannabis plant material is immersed and agitated. The filtered mixture of cooling agent and cannabis plant material is provided to a separator to extract the compounds of interest, while concurrently a second filter basket is charged with cannabis plant material. The system includes a transfer mechanism to move the respective filter baskets in and out of the tank as required.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
The technology relates to systems and methods for providing medicine recommendations using a population model generated from aggregate patient information. The systems and methods include a feedback system whereby the efficacy and side effects experienced by patients can be linked to their genetic information to enhance the accuracy of the population model.
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
G16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
G16H 70/40 - ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
G16H 80/00 - ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
11.
SYSTEMS AND METHODS FOR PROVIDING MEDICINE RECOMMENDATIONS
The technology relates to systems and methods for providing medicine recommendations using a population model generated from aggregate patient information. The systems and methods include a feedback system whereby the efficacy and side effects experienced by patients can be linked to their genetic information to enhance the accuracy of the population model.
G16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
G16H 70/40 - ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
G16H 80/00 - ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
12.
SYSTEMS AND METHODS FOR PROVIDING MEDICINE RECOMMENDATIONS
The technology relates to systems and methods of providing medicine recommendations based on the presence or absence of single nucleotide polymorphisms (SNPs). In examples of the technology, a person's genetic information is analysed to identify SNPs relating to potential risk factors for administration of a cannabinoid containing medicine and / or likely metabolism of cannabinoid containing medicines, and then provides medicine recommendations.
G16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
G16H 70/40 - ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
G16H 80/00 - ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
13.
SYSTEMS, DEVICES AND METHODS OF STORING, SELLING, ACCESSING AND DISPENSING OF MEDICINES
Described are systems, devices and methods of storing, selling, accessing and dispensing medicines. The technology may find particular application in the storage, sale, providing access to and dispensing of controlled substances or unapproved medicines, such as those containing opioids and marijuana extracts and structural analogs thereof, or vaccines.
G16H 20/13 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
B65D 83/04 - Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills
A61J 1/03 - Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
patents
